Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review

• Hlavní autoři: Sara Colomer-Lahiguera (Autor), Denise Bryant-Lukosius (Autor), Sarah Rietkoetter (Autor), Lorraine Martelli (Autor), Karin Ribi (Autor), Donna Fitzpatrick-Lewis (Autor), Diana Sherifali (Autor), Angela Orcurto (Autor), Rosalyn Juergens (Autor), Manuela Eicher (Autor)
• Médium: Kniha
• Vydáno: SpringerOpen, 2020-07-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains unclear to what extent current PRO instruments capture...